BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30949194)

  • 21. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of A-to-I RNA editing in cancer development.
    Xu X; Wang Y; Liang H
    Curr Opin Genet Dev; 2018 Feb; 48():51-56. PubMed ID: 29127844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of RNA editome in primary and metastatic lung adenocarcinomas.
    Peng L; Lee LJ; Xiong H; Su H; Rao J; Xiao D; He J; Wu K; Liu D
    Oncotarget; 2017 Feb; 8(7):11517-11529. PubMed ID: 28009993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human coding RNA editing is generally nonadaptive.
    Xu G; Zhang J
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3769-74. PubMed ID: 24567376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
    Gu T; Fu AQ; Bolt MJ; White KP
    JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.
    Osenberg S; Paz Yaacov N; Safran M; Moshkovitz S; Shtrichman R; Sherf O; Jacob-Hirsch J; Keshet G; Amariglio N; Itskovitz-Eldor J; Rechavi G
    PLoS One; 2010 Jun; 5(6):e11173. PubMed ID: 20574523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
    Chen J; Wang L; Wang F; Liu J; Bai Z
    Front Oncol; 2020; 10():37. PubMed ID: 32117713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Integrative Studies on the Functional A-to-I RNA Editing Events in Human Cancers.
    Wu S; Fan Z; Kim P; Huang L; Zhou X
    Genomics Proteomics Bioinformatics; 2023 Jun; 21(3):619-631. PubMed ID: 36708807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAR-mediated RNA editing in non-coding RNA sequences.
    Yang Y; Zhou X; Jin Y
    Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC.
    Mei Y; Liang D; Ai B; Wang T; Guo S; Jin G; Yu D
    Front Oncol; 2023; 13():1092046. PubMed ID: 36895481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Analysis of RNA Editing Events in Ovarian Serous Cystadenoma Using RNA-seq Data.
    Wang Y; Song X; Xu T
    Curr Gene Ther; 2021; 21(3):258-269. PubMed ID: 33573552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes.
    Bazak L; Haviv A; Barak M; Jacob-Hirsch J; Deng P; Zhang R; Isaacs FJ; Rechavi G; Li JB; Eisenberg E; Levanon EY
    Genome Res; 2014 Mar; 24(3):365-76. PubMed ID: 24347612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A porcine brain-wide RNA editing landscape.
    Huang J; Lin L; Dong Z; Yang L; Zheng T; Gu W; Zhang Y; Yin T; Sjöstedt E; Mulder J; Uhlén M; Kristiansen K; Bolund L; Luo Y
    Commun Biol; 2021 Jun; 4(1):717. PubMed ID: 34112917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
    Peng X; Xu X; Wang Y; Hawke DH; Yu S; Han L; Zhou Z; Mojumdar K; Jeong KJ; Labrie M; Tsang YH; Zhang M; Lu Y; Hwu P; Scott KL; Liang H; Mills GB
    Cancer Cell; 2018 May; 33(5):817-828.e7. PubMed ID: 29706454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of constitutive A-to-I editing sites from human transcriptomes in the absence of genomic sequences.
    Zhu S; Xiang JF; Chen T; Chen LL; Yang L
    BMC Genomics; 2013 Mar; 14():206. PubMed ID: 23537002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De Novo A-to-I RNA Editing Discovery in lncRNA.
    Silvestris DA; Scopa C; Hanchi S; Locatelli F; Gallo A
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolutionary analysis reveals regulatory and functional landscape of coding and non-coding RNA editing.
    Zhang R; Deng P; Jacobson D; Li JB
    PLoS Genet; 2017 Feb; 13(2):e1006563. PubMed ID: 28166241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome.
    Peng Z; Cheng Y; Tan BC; Kang L; Tian Z; Zhu Y; Zhang W; Liang Y; Hu X; Tan X; Guo J; Dong Z; Liang Y; Bao L; Wang J
    Nat Biotechnol; 2012 Feb; 30(3):253-60. PubMed ID: 22327324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.